[Anemia among patients with uterine fibroids]

The aim of the study is to know the incidence of anemia in patients with uterine fibroids. This study is practical, prospective, case-control. The study included 67 symptomatic patients with uterine fibroids, [it means that they suffered from one or more of these problems: abnormal uterine bleeding, pressure symptoms and pain]. The results in this study's group were compared with the control group which included 100 patients who don't complain form uterine fibroids. Hemoglobin and hematocrit were evaluated in all patients to know the incidence of anemia among the study's patients in accordance with the criteria of world health organization which concern with anemia. The incidence of anemia among patients in study's group is 53.73%, while it is 26% among patients of the control group. [P 0.001]. we think that the high incidence of anemia in symptomatic patients with uterine fibroids is related to the chronic loss of blood which caused by the organic abnormal uterine bleeding, from which complain 71.64% of study's group patients, while suffered from this complaint only 6% of control group patients.

The management of abnormal uterine bleeding in patients with uterine fibroids

Background and Objective: evaluation the treatment of organic abnormal uterine bleeding [OAUB] caused by uterine fibroids using intra uterine device [IUD] releasing levonorgestrel.. Methods: This practical, prospective included 43 patients complaining from OABD, exactly from menorrhagia, hypermenorrhea or from both together simultaneously, sometimes. The final diagnosis is made after exclusion the non organic causes of AUB: dysfunctional uterine bleeding and the other organic causes except uterine fibroids. The management by IUD – releasing levonorgestrel in the rate of 20ug/24 hours is applied on each patient of our study Results: The follow – up of the patients after 6 months from the onset of treatment revealed: 26 patients [60.46%] relieved form AUB, whereas the number of patients who relieved from AUB after one year from the onset treatment increased to 35 patients [81.39%]. Conclusions: According the study's data, this method of management AUB is considered very efficient and safe, encouraging us to apply it. KeyWords: Organic abnormal uterine bleeding, Intra uterine device – releasing levonorgestrel